Eytan Stein
MD
Associate Attending, Leukemia Service
👥Biography 个人简介
Eytan Stein is a leading expert in IDH-mutated AML and has been a principal investigator on pivotal trials for both enasidenib (IDH2 inhibitor) and ivosidenib (IDH1 inhibitor). His work has defined the clinical activity and toxicity profile of IDH inhibitors, including the critical management of differentiation syndrome. He has contributed to understanding IDH inhibitor resistance and rational combination strategies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Eytan Stein 的研究动态
Follow Eytan Stein's research updates
留下邮箱，当我们发布与 Eytan Stein（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment